Additional information as at 30 June 2025
Consolidated management report as at 30 June 2025
Notes to the consolidated financial report as at 30 June 2025
Consolidated financial report according to IFRS as at 30 June 2025
Notification of sale of treasury shares as of 28 August, 2025
Sofia, Bulgaria, August 28, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 27, 2025 the Company sold 43 600 (forty-three thousand and six hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 108 248.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.
Notification of sale of treasury shares as of 27 August, 2025
Sofia, Bulgaria, August 27, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 26, 2025 the Company sold 49 801 (forty-nine thousand eight hundred and one) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 123 510.05 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.
Notification of sale of treasury shares as of 26 August, 2025
Sofia, Bulgaria, August 26, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 25, 2025 the Company sold 303 540 (three hundred three thousand five hundred and forty) treasury shares representing 0.06% of the share capital of the Company, at a total value of BGN 747 218.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.
Notification of sale of treasury shares as of 25 August, 2025
Sofia, Bulgaria, August 25, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 22, 2025 the Company sold 99 775 (ninety-nine thousand seven hundred and seventy-five) treasury shares representing 0.02% of the share capital of the Company, at a total value of BGN 244 852.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.
Notification of sale of treasury shares as of 22 August, 2025
Sofia, Bulgaria, August 22, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 21, 2025 the Company sold 17 126 (seventeen thousand one hundred and twenty-six) treasury shares representing 0.003% of the share capital of the Company, at a total value of BGN 41 961.96 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.